melanotan-ii has been researched along with dinoprostone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hsiao, YH; Tai, MH; Tsai, HE; Wu, CS; Wu, JC; Wu, JS | 1 |
1 other study(ies) available for melanotan-ii and dinoprostone
Article | Year |
---|---|
Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation and Cyclooxygenase II Inhibition.
Topics: alpha-MSH; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Humans; Immunohistochemistry; Melanoma, Experimental; Mice; Models, Biological; Peptides, Cyclic; Phosphorylation; PTEN Phosphohydrolase; Receptor, Melanocortin, Type 1; Signal Transduction; Up-Regulation | 2020 |